Profarma Financial Statements From 2010 to 2024
| PFRM3 Stock | BRL 5.91 0.15 2.60% |
Check Profarma Distribuidora financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Profarma main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Profarma financial statements analysis is a perfect complement when working with Profarma Distribuidora Valuation or Volatility modules.
Profarma |
Profarma Distribuidora de Company Return On Equity Analysis
Profarma Distribuidora's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Profarma Distribuidora Return On Equity | 0.0645 |
Most of Profarma Distribuidora's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Profarma Distribuidora de is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Profarma Distribuidora de has a Return On Equity of 0.0645. This is 100.27% lower than that of the Health Care Providers & Services sector and 99.13% lower than that of the Health Care industry. The return on equity for all Brazil stocks is 120.81% lower than that of the firm.
Profarma Distribuidora Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Profarma Distribuidora's current stock value. Our valuation model uses many indicators to compare Profarma Distribuidora value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Profarma Distribuidora competition to find correlations between indicators driving Profarma Distribuidora's intrinsic value. More Info.Profarma Distribuidora de is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies reporting about 0.57 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Profarma Distribuidora de is roughly 1.75 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Profarma Distribuidora by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Profarma Distribuidora's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Profarma Distribuidora's earnings, one of the primary drivers of an investment's value.About Profarma Distribuidora Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Profarma Distribuidora income statement, its balance sheet, and the statement of cash flows. Profarma Distribuidora investors use historical funamental indicators, such as Profarma Distribuidora's revenue or net income, to determine how well the company is positioned to perform in the future. Although Profarma Distribuidora investors may use each financial statement separately, they are all related. The changes in Profarma Distribuidora's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Profarma Distribuidora's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Profarma Distribuidora Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Profarma Distribuidora. Please read more on our technical analysis and fundamental analysis pages.
Profarma Distrib Prod Farmaceuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil. PROFARMA operates under Medical Distribution classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 6327 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Profarma Distribuidora in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Profarma Distribuidora's short interest history, or implied volatility extrapolated from Profarma Distribuidora options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Profarma Distribuidora using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Profarma Distribuidora Correlation against competitors. Note that the Profarma Distribuidora information on this page should be used as a complementary analysis to other Profarma Distribuidora's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Profarma Stock analysis
When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |